[{"id":"30869735-a511-4b8a-aed0-58cf67b563b0","acronym":"","url":"https://clinicaltrials.gov/study/NCT03943394","created_at":"2021-01-18T19:25:01.944Z","updated_at":"2024-07-02T16:36:59.769Z","phase":"","brief_title":"PCM1-JAK2 in Therapy Related Neoplasms","source_id_and_acronym":"NCT03943394","lead_sponsor":"Assiut University","biomarkers":" JAK2 • PCM1","pipe":" | ","alterations":" PCM1-JAK2 fusion • JAK2 fusion • PCM1-JAK2 fusion","tags":["JAK2 • PCM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PCM1-JAK2 fusion • JAK2 fusion • PCM1-JAK2 fusion"],"overall_status":"Unknown status","enrollment":" Enrollment 140","initiation":"Initiation: 06/01/2019","start_date":" 06/01/2019","primary_txt":" Primary completion: 06/01/2021","primary_completion_date":" 06/01/2021","study_txt":" Completion: 06/01/2022","study_completion_date":" 06/01/2022","last_update_posted":"2019-05-09"}]